Moshe E. Gatt

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

Life Sciences, Hematology, Pharmacology +15

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka et al. · The Lancet · 2020 · 324 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Guy Ledergor, Assaf Weiner, Mor Zada et al. · Nature Medicine · 2018 · 280 citations · Full text

Medicine, Cell Biology, Hematology +14

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Yaël C. Cohen, Mor Zada, Shuang-Yin Wang et al. · Nature Medicine · 2021 · 246 citations · Full text

Medicine, Molecular Medicine, Oncology +17

BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells

Mala Mani, Daniel E. Carrasco, Yunyu Zhang et al. · Cancer Research · 2009 · 182 citations

Medicine, Cancer Biology, Oncology +17